ID

15971

Description

Adjunctive Vortioxetine in Schizophrenia; ODM derived from: https://clinicaltrials.gov/show/NCT02357797

Link

https://clinicaltrials.gov/show/NCT02357797

Keywords

Versions (1)
  1. 6/22/16 6/22/16 -
Uploaded on

June 22, 2016

DOI

To request one please log in.

License

Creative Commons BY 4.0
Model comments :

You can comment on the data model here. Via the speech bubbles at the itemgroups and items you can add comments to those specificially.

Back to model comments
Itemgroup comments for :

Item comments for :

In order to download data models you must be logged in. Please log in or register for free.

Eligibility Schizophrenia NCT02357797

English

Eligibility Schizophrenia NCT02357797

1 forms  
Inclusion Criteria
Description

Inclusion Criteria

Alias
UMLS CUI
C1512693
1. outpatient
Description

Outpatient

Data type

boolean

Alias
UMLS CUI [1]
C0029921
2. scid diagnosis of schizophrenia
Description

Schizophrenia

Data type

boolean

Alias
UMLS CUI [1]
C0036341
3. age 18-65 years old
Description

Age

Data type

boolean

Alias
UMLS CUI [1]
C0001779
4. treated with an adequate dose of one or a maximum of two antipsychotic medications for at least 3 months, with a stable dose for at least the last 4 weeks, and willing to continue for up to 16 weeks.
Description

Antipsychotic Agents | Dosage Adequate | Dosage Stable

Data type

boolean

Alias
UMLS CUI [1]
C0040615
UMLS CUI [2,1]
C0178602
UMLS CUI [2,2]
C0205411
UMLS CUI [3,1]
C0178602
UMLS CUI [3,2]
C0205360
5. no antidepressant treatment for at least 8 weeks prior to randomization.
Description

Antidepressant therapy Absent

Data type

boolean

Alias
UMLS CUI [1,1]
C1096649
UMLS CUI [1,2]
C0332197
6. treatment with other concomitant, non-antipsychotic, psychiatric medications is allowed, but must be unchanged for at least 8 weeks, with a stable dose for at least the last 4 weeks, and willing to continue for 16 weeks. benzodiazepines must not be given within 8 hours of the cognitive assessment. treatment with non-psychiatric medications is unrestricted.
Description

Pharmaceutical Preparations psychiatric concomitant | Benzodiazepines | Assessment: Cognition

Data type

boolean

Alias
UMLS CUI [1,1]
C0013227
UMLS CUI [1,2]
C0205487
UMLS CUI [1,3]
C0521115
UMLS CUI [2]
C0005064
UMLS CUI [3]
C0870300
7. panss negative subscore >14 with at least two of the items at a level >/=4 (moderate)
Description

Positive and negative syndrome scale Negative | Level Moderate

Data type

boolean

Alias
UMLS CUI [1,1]
C0451383
UMLS CUI [1,2]
C0205160
UMLS CUI [2,1]
C0441889
UMLS CUI [2,2]
C0205081
8. panss positive subscore </=14 with not more than one of the items at a level >/=4 (moderate)
Description

Positive and negative syndrome scale Positive | Level Moderate

Data type

boolean

Alias
UMLS CUI [1,1]
C0451383
UMLS CUI [1,2]
C1446409
UMLS CUI [2,1]
C0441889
UMLS CUI [2,2]
C0205081
9. hamd-17 total score </=12
Description

HAMD-17 - Total Score

Data type

boolean

Alias
UMLS CUI [1]
C3639399
10. simpson angus score of any item <3
Description

ID.10

Data type

boolean

11. english-speaking
Description

Able to speak English Language

Data type

boolean

Alias
UMLS CUI [1,1]
C0564215
UMLS CUI [1,2]
C0376245
12. competent and willing to sign informed consent
Description

Informed consent

Data type

boolean

Alias
UMLS CUI [1]
C0021430
Exclusion Criteria
Description

Exclusion Criteria

Alias
UMLS CUI
C0680251
1. structural brain disease
Description

Structural brain disorder

Data type

boolean

Alias
UMLS CUI [1]
C0851391
2. mental retardation by history and estimated iq <70 (wrat-iii word reading)
Description

Mental Retardation | Intelligence quotient

Data type

boolean

Alias
UMLS CUI [1]
C0025362
UMLS CUI [2]
C0456149
3. autism-spectrum disorder diagnosis by history
Description

Autism Spectrum Disorder

Data type

boolean

Alias
UMLS CUI [1]
C1510586
4. any serious chronic medical illnesses that in the view of the investigator will interfere with the patient's ability to comply with the study procedures or that will interfere with cognition.
Description

Chronic disease Interferes with Compliance behavior Study Protocol | Chronic disease Interferes with Cognition

Data type

boolean

Alias
UMLS CUI [1,1]
C0008679
UMLS CUI [1,2]
C0521102
UMLS CUI [1,3]
C1321605
UMLS CUI [1,4]
C2348563
UMLS CUI [2,1]
C0008679
UMLS CUI [2,2]
C0521102
UMLS CUI [2,3]
C0009240
5. active substance abuse or dependence in the past 8 weeks
Description

Substance Use Disorders | Substance Dependence

Data type

boolean

Alias
UMLS CUI [1]
C0038586
UMLS CUI [2]
C0038580
6. intolerance to or inefficacy of vortioxetine in the past
Description

intolerance to vortioxetine | vortioxetine ineffective

Data type

boolean

Alias
UMLS CUI [1,1]
C1744706
UMLS CUI [1,2]
C3661282
UMLS CUI [2,1]
C3661282
UMLS CUI [2,2]
C3242229
7. acute anger to self or others as per investigator assessment
Description

Persistent anger with self or others

Data type

boolean

Alias
UMLS CUI [1]
C1718201
8. pregnant or breastfeeding females
Description

Pregnancy | Breast Feeding

Data type

boolean

Alias
UMLS CUI [1]
C0032961
UMLS CUI [2]
C0006147
9. unwilling or unable to be sexually abstinent or not using an effective form of birth control if they are sexually active
Description

Sexual Abstinence Unwilling | Sexual Abstinence Unable | Contraceptive methods Not used

Data type

boolean

Alias
UMLS CUI [1,1]
C0036899
UMLS CUI [1,2]
C0558080
UMLS CUI [2,1]
C0036899
UMLS CUI [2,2]
C1299582
UMLS CUI [3,1]
C0700589
UMLS CUI [3,2]
C0445107
10. current treatment with a monoamine oxidase inhibitor (maoi)
Description

Therapeutic procedure Monoamine Oxidase Inhibitor

Data type

boolean

Alias
UMLS CUI [1,1]
C0087111
UMLS CUI [1,2]
C0026457
Back to the top of the page

Similar models

Eligibility Schizophrenia NCT02357797

1 forms
Name
Type
Description | Question | Decode (Coded Value)
Data type
Alias
Item Group
C1512693 (UMLS CUI)
Outpatient
Item
1. outpatient
boolean
C0029921 (UMLS CUI [1])
Schizophrenia
Item
2. scid diagnosis of schizophrenia
boolean
C0036341 (UMLS CUI [1])
Age
Item
3. age 18-65 years old
boolean
C0001779 (UMLS CUI [1])
Antipsychotic Agents | Dosage Adequate | Dosage Stable
Item
4. treated with an adequate dose of one or a maximum of two antipsychotic medications for at least 3 months, with a stable dose for at least the last 4 weeks, and willing to continue for up to 16 weeks.
boolean
C0040615 (UMLS CUI [1])
C0178602 (UMLS CUI [2,1])
C0205411 (UMLS CUI [2,2])
C0178602 (UMLS CUI [3,1])
C0205360 (UMLS CUI [3,2])
Antidepressant therapy Absent
Item
5. no antidepressant treatment for at least 8 weeks prior to randomization.
boolean
C1096649 (UMLS CUI [1,1])
C0332197 (UMLS CUI [1,2])
Pharmaceutical Preparations psychiatric concomitant | Benzodiazepines | Assessment: Cognition
Item
6. treatment with other concomitant, non-antipsychotic, psychiatric medications is allowed, but must be unchanged for at least 8 weeks, with a stable dose for at least the last 4 weeks, and willing to continue for 16 weeks. benzodiazepines must not be given within 8 hours of the cognitive assessment. treatment with non-psychiatric medications is unrestricted.
boolean
C0013227 (UMLS CUI [1,1])
C0205487 (UMLS CUI [1,2])
C0521115 (UMLS CUI [1,3])
C0005064 (UMLS CUI [2])
C0870300 (UMLS CUI [3])
Positive and negative syndrome scale Negative | Level Moderate
Item
7. panss negative subscore >14 with at least two of the items at a level >/=4 (moderate)
boolean
C0451383 (UMLS CUI [1,1])
C0205160 (UMLS CUI [1,2])
C0441889 (UMLS CUI [2,1])
C0205081 (UMLS CUI [2,2])
Positive and negative syndrome scale Positive | Level Moderate
Item
8. panss positive subscore </=14 with not more than one of the items at a level >/=4 (moderate)
boolean
C0451383 (UMLS CUI [1,1])
C1446409 (UMLS CUI [1,2])
C0441889 (UMLS CUI [2,1])
C0205081 (UMLS CUI [2,2])
HAMD-17 - Total Score
Item
9. hamd-17 total score </=12
boolean
C3639399 (UMLS CUI [1])
ID.10
Item
10. simpson angus score of any item <3
boolean
Able to speak English Language
Item
11. english-speaking
boolean
C0564215 (UMLS CUI [1,1])
C0376245 (UMLS CUI [1,2])
Informed consent
Item
12. competent and willing to sign informed consent
boolean
C0021430 (UMLS CUI [1])
Item Group
C0680251 (UMLS CUI)
Structural brain disorder
Item
1. structural brain disease
boolean
C0851391 (UMLS CUI [1])
Mental Retardation | Intelligence quotient
Item
2. mental retardation by history and estimated iq <70 (wrat-iii word reading)
boolean
C0025362 (UMLS CUI [1])
C0456149 (UMLS CUI [2])
Autism Spectrum Disorder
Item
3. autism-spectrum disorder diagnosis by history
boolean
C1510586 (UMLS CUI [1])
Chronic disease Interferes with Compliance behavior Study Protocol | Chronic disease Interferes with Cognition
Item
4. any serious chronic medical illnesses that in the view of the investigator will interfere with the patient's ability to comply with the study procedures or that will interfere with cognition.
boolean
C0008679 (UMLS CUI [1,1])
C0521102 (UMLS CUI [1,2])
C1321605 (UMLS CUI [1,3])
C2348563 (UMLS CUI [1,4])
C0008679 (UMLS CUI [2,1])
C0521102 (UMLS CUI [2,2])
C0009240 (UMLS CUI [2,3])
Substance Use Disorders | Substance Dependence
Item
5. active substance abuse or dependence in the past 8 weeks
boolean
C0038586 (UMLS CUI [1])
C0038580 (UMLS CUI [2])
intolerance to vortioxetine | vortioxetine ineffective
Item
6. intolerance to or inefficacy of vortioxetine in the past
boolean
C1744706 (UMLS CUI [1,1])
C3661282 (UMLS CUI [1,2])
C3661282 (UMLS CUI [2,1])
C3242229 (UMLS CUI [2,2])
Persistent anger with self or others
Item
7. acute anger to self or others as per investigator assessment
boolean
C1718201 (UMLS CUI [1])
Pregnancy | Breast Feeding
Item
8. pregnant or breastfeeding females
boolean
C0032961 (UMLS CUI [1])
C0006147 (UMLS CUI [2])
Sexual Abstinence Unwilling | Sexual Abstinence Unable | Contraceptive methods Not used
Item
9. unwilling or unable to be sexually abstinent or not using an effective form of birth control if they are sexually active
boolean
C0036899 (UMLS CUI [1,1])
C0558080 (UMLS CUI [1,2])
C0036899 (UMLS CUI [2,1])
C1299582 (UMLS CUI [2,2])
C0700589 (UMLS CUI [3,1])
C0445107 (UMLS CUI [3,2])
Therapeutic procedure Monoamine Oxidase Inhibitor
Item
10. current treatment with a monoamine oxidase inhibitor (maoi)
boolean
C0087111 (UMLS CUI [1,1])
C0026457 (UMLS CUI [1,2])
Back to the top of the page 

Contact

Please use this form for feedback, questions and suggestions for improvements.

Fields marked with * are required.

Help

Do you need help on how to use the search function? Please watch the corresponding tutorial video for more details and learn how to use the search function most efficiently.

Watch Tutorial